Need Help?

Somatic point mutation data from microsatellite unstable colorectal cancers

The dataset contains the somatic point mutation data from the exome-targeted region of 36 exome or whole genome sequenced microsatellite unstable colorectal cancers and the somatic point mutation data from 93 additional MiSeq sequenced microsatellite unstable colorectal cancers.

Request Access

Data Access Agreement of the study "Somatic point mutation data from microsatellite unstable colorectal cancers (EGAS00001003101)"

Data Access Agreement of the study Somatic point mutation data from microsatellite unstable colorectal cancers (EGAS00001003101) This agreement governs the terms of access to the controlled access datasets generated by the Department of Cancer Genetics of the University of Helsinki. In signing this agreement, you agree to be bound by the terms and conditions of access set out therein. For the sake of clarity, the terms of access set out in this agreement apply to the User and to the User Institution(s) (as defined below). The current agreement is limited to the data set EGAS00001003101 (as defined below) and does not cover other data generated at the different centres participating in the project. Definitions Data Producer: Department of Cancer Genetics of the University of Helsinki External Collaborator: A collaborator of the User, working for an institution other than the User Institution(s) (see below for definitions of User and User Institution(s)). Data set: The Controlled Access Datasets of the study EGAS00001003101 generated by the Data Producer. Project: “Somatic point mutation data from microsatellite unstable colorectal cancers” Research Participant: An individual having contributed their personal data to the project. User: An applicant (principal investigator), having signed this Data Access Agreement, whose User Institution has co-signed this Data Access Agreement, both of them having received acknowledgement of its acceptance. User Institution(s): Institution(s) at which the User is employed, affiliated or enrolled. A representative of it has co-signed this Data Access Agreement with the User and received acknowledgement of its acceptance. Terms and Conditions: In signing this Agreement: 1. The User and the User Institution(s) agree to use the Data only for the advancement of medical research. And not to use the data for the creation of products for sale or for any commercial purpose. 2. The User and the User Institution(s) agree to use the Data for no other purpose than the approved purpose and project described in the collaboration proposal; use of the Data for a other/new purpose or project will require a new application and approval. 3. The User and the User Institution(s) agree to preserve, at all times, the confidentiality of the information and Data set. In particular, they undertake not to use, or attempt to use the Data set to compromise or otherwise infringe the confidentiality of information on Research Participants. 4. The User and the User Institution(s) agree to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. The User and the User Institution(s) agree not to pursue any research with the goal to identify Research Participants and not to link or combine the Data set provided under this agreement to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User and the User Institution(s), or is freely available without restriction. 5. The User and the User Institution(s) agree not to transfer or disclose the Data set, in whole or part, or any material derived from the Data set, to anyone not listed in this application form, except as necessary for data safety monitoring, national audits or program management. Should the User or the User Institution(s) wish to share the Data set with an External Collaborator, the External Collaborator must complete a separate Collaborator's Form for Access to the Data set. 6. The User and the User Institution(s) accept that the Data is protected by and subject to international laws, including but not limited to the UK Data Protection Act 1998, and that You are responsible for ensuring compliance with any such applicable law. The Consortium Data Access Committee reserves the right to request and inspect data security and management documentation to ensure the adequacy of data protection measures in countries that have no national laws comparable to that which pertain in the EAA. 7. The User and the User Institution(s) accept that Data producers, depositors or copyright holders, or the funders of the Data set or any part of the Data set supplied: a) bear no legal responsibility for the accuracy or comprehensiveness of the Data set; b) accept no liability for indirect, consequential, or incidental, damages or losses arising from use of the Data set, or from the unavailability of, interruption in Data set access for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data set, over and above that published by the Consortium. 8. The User and the User Institution(s) agree not to make intellectual property claims on the Data set (including somatic mutations) and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of the Data set, or conclusion drawn directly from the Data set. 9. The User and the User Institution(s) can elect to perform further research that would add intellectual and resource capital to the data set and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User and the User Institution(s) agree to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health’s, Best Practices for the Licensing of Genomic Inventions or a similar national guideline that is in conformity with the OECD, Guidelines for the Licensing of the Genetic Inventions. 10. The User shall be free to publish the results of the research using the Data for the approved purpose. The User agrees to acknowledge in any such publication that the research makes use of Data generated by the Data Producer. 11. The User and the User Institution(s) agree to destroy any Data held, once it is no longer used for the indicated project described in this application form unless obligated to retain the data set for archival purposes in conformity with national audits or legal requirements. 12. The User and the User Institution(s) will notify the Data Access Committee as soon as they become aware of a breach of the terms or conditions of this agreement. 13. The User and the User Institution(s) agree that they will submit a final report to the Data Access Committee sixty (60) days on completion of the agreed purpose. The Data Access Committee agrees to treat the report and all information, data, results, and conclusions contained within such report as confidential information belonging to the User Institution. 14. If requested, the User and the User Institution(s) will allow data security and management documentation and corresponding physical installations to be inspected to verify that they are complying with the terms of this Data Access Agreement. 15. This Agreement shall be effective as of the date of the last party to sign below (“Effective Date”) and shall terminate three (3) years after the Effective Date, unless terminated sooner pursuant to Section 16 below. 16. The User and the User Institution(s) accept that this agreement may terminate immediately upon any breach of this agreement from the User and the User Institution(s). Either Party may terminate this Agreement upon thirty (30) days written notice for any reason. 17. In case of section 15 or 16 the User and the User Institution(s) will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User and the User Institution(s) from retaining the data set for archival purpose in conformity with national audits or legal requirements. 18. The following Sections of this Agreement shall survive its expiration or termination: Sections 1-11, 13-15, 19. 19. The User and the User Institution(s) agree to distribute a copy of this agreement and explain its content to any person mentioned in this application form. 20. This agreement shall be construed, interpreted and governed by the laws of Finland and shall be subject to the non-exclusive jurisdiction of the Finnish courts. For and on behalf of University of Helsinki _____________________________________________________ Signature of Institutional or Administrative Authority Print name ___________________________ Date ___________________________ Stamp For University of Helsinki, Department of Cancer Genetics _________________________________________________ Signature Print Name ___________________________ Date ___________________________ Stamp For and on behalf of User: Name of Applicant(s): ___________________________ ___________________________ ___________________________ ___________________________ Signature of Applicant(s): ___________________________ ___________________________ ___________________________ ___________________________ Date: ___________________________ For and on behalf of User Institution: Signature of Institutional or Administrative Authority: ___________________________ Print name: ___________________________ User Institution: ___________________________ Date: ___________________________ STAMP:

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001003101 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00002058264 vcf 265.4 kB
EGAF00002058265 vcf 287.8 kB
EGAF00002058266 vcf 248.8 kB
EGAF00002058267 vcf 257.3 kB
EGAF00002058268 vcf 286.8 kB
EGAF00002058269 vcf 280.7 kB
EGAF00002058270 vcf 287.0 kB
EGAF00002058271 vcf 248.7 kB
EGAF00002058272 vcf 267.8 kB
EGAF00002058273 vcf 239.9 kB
EGAF00002058274 vcf 277.7 kB
EGAF00002058275 vcf 242.1 kB
EGAF00002058276 vcf 241.9 kB
EGAF00002058277 vcf 241.9 kB
EGAF00002058278 vcf 242.2 kB
EGAF00002058279 vcf 242.1 kB
EGAF00002058280 vcf 241.4 kB
EGAF00002058281 vcf 241.8 kB
EGAF00002058282 vcf 241.0 kB
EGAF00002058283 vcf 242.4 kB
EGAF00002058284 vcf 242.2 kB
EGAF00002058285 vcf 241.6 kB
EGAF00002058286 vcf 241.6 kB
EGAF00002058287 vcf 242.3 kB
EGAF00002058288 vcf 269.7 kB
EGAF00002058289 vcf 249.9 kB
EGAF00002058290 vcf 249.0 kB
EGAF00002058291 vcf 279.0 kB
EGAF00002058292 vcf 280.8 kB
EGAF00002058293 vcf 282.0 kB
EGAF00002058294 vcf 264.9 kB
EGAF00002058295 vcf 274.9 kB
EGAF00002058296 vcf 272.1 kB
EGAF00002058297 vcf 269.4 kB
EGAF00002058298 vcf 264.9 kB
EGAF00002058299 vcf 241.7 kB
EGAF00002058300 vcf 242.2 kB
EGAF00002058301 vcf 241.8 kB
EGAF00002058302 vcf 241.3 kB
EGAF00002058303 vcf 241.4 kB
EGAF00002058304 vcf 242.3 kB
EGAF00002058305 vcf 242.0 kB
EGAF00002058306 vcf 241.7 kB
EGAF00002058307 vcf 242.4 kB
EGAF00002058308 vcf 241.0 kB
EGAF00002058309 vcf 243.3 kB
EGAF00002058310 vcf 241.6 kB
EGAF00002058311 vcf 241.8 kB
EGAF00002058312 vcf 241.6 kB
EGAF00002058313 vcf 244.0 kB
EGAF00002058314 vcf 267.1 kB
EGAF00002058315 vcf 313.8 kB
EGAF00002058316 vcf 253.7 kB
EGAF00002058317 vcf 266.2 kB
EGAF00002058318 vcf 274.4 kB
EGAF00002058319 vcf 251.0 kB
EGAF00002058320 vcf 330.3 kB
EGAF00002058321 vcf 245.5 kB
EGAF00002058322 vcf 304.6 kB
EGAF00002058323 vcf 238.8 kB
EGAF00002058324 vcf 242.5 kB
EGAF00002058325 vcf 242.1 kB
EGAF00002058326 vcf 241.5 kB
EGAF00002058327 vcf 241.2 kB
EGAF00002058328 vcf 242.0 kB
EGAF00002058329 vcf 242.2 kB
EGAF00002058330 vcf 241.9 kB
EGAF00002058331 vcf 241.4 kB
EGAF00002058332 vcf 242.1 kB
EGAF00002058333 vcf 241.8 kB
EGAF00002058334 vcf 241.9 kB
EGAF00002058335 vcf 241.9 kB
EGAF00002058336 vcf 242.5 kB
EGAF00002058337 vcf 241.7 kB
EGAF00002058338 vcf 256.7 kB
EGAF00002058339 vcf 314.5 kB
EGAF00002058340 vcf 369.6 kB
EGAF00002058341 vcf 241.1 kB
EGAF00002058342 vcf 241.7 kB
EGAF00002058343 vcf 241.8 kB
EGAF00002058344 vcf 241.9 kB
EGAF00002058345 vcf 240.6 kB
EGAF00002058346 vcf 241.9 kB
EGAF00002058347 vcf 240.8 kB
EGAF00002058348 vcf 241.9 kB
EGAF00002058349 vcf 241.6 kB
EGAF00002058350 vcf 241.7 kB
EGAF00002058351 vcf 242.9 kB
EGAF00002058352 vcf 242.2 kB
EGAF00002058353 vcf 242.6 kB
EGAF00002058354 vcf 242.5 kB
EGAF00002058355 vcf 242.1 kB
EGAF00002058356 vcf 241.7 kB
EGAF00002058357 vcf 241.5 kB
EGAF00002058358 vcf 242.4 kB
EGAF00002058359 vcf 242.2 kB
EGAF00002058360 vcf 242.0 kB
EGAF00002058361 vcf 241.2 kB
EGAF00002058362 vcf 241.7 kB
EGAF00002058363 vcf 241.1 kB
EGAF00002058364 vcf 241.2 kB
EGAF00002058365 vcf 242.1 kB
EGAF00002058366 vcf 241.2 kB
EGAF00002058367 vcf 241.7 kB
EGAF00002058368 vcf 241.4 kB
EGAF00002058369 vcf 241.8 kB
EGAF00002058370 vcf 241.2 kB
EGAF00002058371 vcf 241.4 kB
EGAF00002058372 vcf 241.7 kB
EGAF00002058373 vcf 241.2 kB
EGAF00002058374 vcf 242.3 kB
EGAF00002058375 vcf 241.4 kB
EGAF00002058376 vcf 241.4 kB
EGAF00002058377 vcf 242.5 kB
EGAF00002058378 vcf 241.7 kB
EGAF00002058379 vcf 241.8 kB
EGAF00002058380 vcf 241.8 kB
EGAF00002058381 vcf 241.9 kB
EGAF00002058382 vcf 242.2 kB
EGAF00002058383 vcf 242.2 kB
EGAF00002058384 vcf 242.8 kB
EGAF00002058385 vcf 242.2 kB
EGAF00002058386 vcf 242.0 kB
EGAF00002058387 vcf 242.3 kB
EGAF00002058388 vcf 242.3 kB
EGAF00002058389 vcf 241.9 kB
EGAF00002058390 vcf 242.4 kB
EGAF00002058391 vcf 241.6 kB
EGAF00002058392 vcf 241.3 kB
129 Files (32.3 MB)